These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23803728)

  • 1. miR-155 meets the JAK/STAT pathway.
    Persson JL
    Cell Cycle; 2013 Jul; 12(14):2170. PubMed ID: 23803728
    [No Abstract]   [Full Text] [Related]  

  • 2. Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155.
    Litvinov IV; Pehr K; Sasseville D
    Cell Cycle; 2013 Jul; 12(14):2172-3. PubMed ID: 23803726
    [No Abstract]   [Full Text] [Related]  

  • 3. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
    Kopp KL; Ralfkiaer U; Gjerdrum LM; Helvad R; Pedersen IH; Litman T; Jønson L; Hagedorn PH; Krejsgaard T; Gniadecki R; Bonefeld CM; Skov L; Geisler C; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Cell Cycle; 2013 Jun; 12(12):1939-47. PubMed ID: 23676217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
    Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
    Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K
    Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
    Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
    Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping each other in check: a reciprocal relationship between cytokines and miRNA.
    Andersen MH
    Cell Cycle; 2013 Jul; 12(14):2171. PubMed ID: 23803727
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
    Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
    Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
    Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R; Hospital M; Suárez-Massa D; Rodriguez-Peralto JL; Postigo C; Leon-Castillo A; González-Vela C; Martinez N; Ortiz-Romero P; Sánchez-Beato M; Piris MÁ; Vaqué JP
    Haematologica; 2015 Nov; 100(11):e450-3. PubMed ID: 26294736
    [No Abstract]   [Full Text] [Related]  

  • 12. JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells.
    Yamada O; Ozaki K; Akiyama M; Kawauchi K
    Mol Cancer Ther; 2012 May; 11(5):1112-21. PubMed ID: 22402124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.
    Peng HY; Jiang SS; Hsiao JR; Hsiao M; Hsu YM; Wu GH; Chang WM; Chang JY; Jin SL; Shiah SG
    Mol Oncol; 2016 Jun; 10(6):895-909. PubMed ID: 27038552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat5 as a diagnostic marker for leukemia.
    Lewis RS; Ward AC
    Expert Rev Mol Diagn; 2008 Jan; 8(1):73-82. PubMed ID: 18088232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three members in JAK/STAT signal pathway from the sea cucumber Apostichopus japonicus: Molecular cloning, characterization and function analysis.
    Shao Y; Li C; Zhang W; Duan X; Li Y; Han Q; Jin C
    Fish Shellfish Immunol; 2015 Oct; 46(2):523-36. PubMed ID: 26206609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate Is a JAK/STAT Pathway Inhibitor.
    Thomas S; Fisher KH; Snowden JA; Danson SJ; Brown S; Zeidler MP
    PLoS One; 2015; 10(7):e0130078. PubMed ID: 26131691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression.
    Goldstein JD; Burlion A; Zaragoza B; Sendeyo K; Polansky JK; Huehn J; Piaggio E; Salomon BL; Marodon G
    PLoS One; 2016; 11(4):e0153682. PubMed ID: 27077371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
    Wingelhofer B; Neubauer HA; Valent P; Han X; Constantinescu SN; Gunning PT; Müller M; Moriggl R
    Leukemia; 2018 Aug; 32(8):1713-1726. PubMed ID: 29728695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD45 recruits adapter protein DOK-1 and negatively regulates JAK-STAT signaling in hematopoietic cells.
    Wu L; Bijian K; Shen SH
    Mol Immunol; 2009 Jul; 46(11-12):2167-77. PubMed ID: 19481264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells.
    Qin JZ; Kamarashev J; Zhang CL; Dummer R; Burg G; Döbbeling U
    J Invest Dermatol; 2001 Sep; 117(3):583-9. PubMed ID: 11564163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.